
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
Andrew Fein Initiated (AMLX) at Strong Buy and Held Target at $35 on, Feb 1st, 2022


🞛 This publication is a summary or evaluation of another publication
Andrew Fein of HC Wainwright & Co., Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $35 on, Feb 1st, 2022.
Andrew, nor any peers, have made any analyst calls on AMLX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30